Tokyo Tape
Sign in
← Terumo

Quarterly report · Q1

4543.TEDINET S100RML8
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥215.3bn2023-04-01 → 2023-06-30Cons.Revenue IFRS
Revenue¥820.2bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥197.3bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Operating income¥29.6bn2023-04-01 → 2023-06-30Cons.Operating profit loss IFRS
Operating income¥30.4bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Profit before tax¥29.8bn2023-04-01 → 2023-06-30Cons.Profit loss before tax IFRS
Profit before tax¥116.1bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥29.7bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥22.5bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥89.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥22.4bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥22.5bn2023-04-01 → 2023-06-30Cons.Profit loss IFRS
Net income¥22.4bn2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Total assets¥1.67Tat 2023-06-30Cons.Assets IFRS
Total assets¥1.60Tat 2023-03-31Cons.Assets IFRS
Total assets¥1.58Tat 2022-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥468.1bnat 2023-06-30Cons.Liabilities IFRS
Total liabilities¥491.2bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥1.20Tat 2023-06-30Cons.Equity IFRS
Net assets / equity¥1.11Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥1.12Tat 2022-06-30Cons.Equity IFRS
Net assets / equity¥1.01Tat 2022-03-31dCons.Equity IFRS
Equity (owners)¥1.20Tat 2023-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.11Tat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.12Tat 2022-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥160.1bnat 2023-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥187.3bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥209.6bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥205.3bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥11.4bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥117.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥23.4bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥19.3bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥59.1bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥16.1bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥27.5bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥86.6bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥14.8bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥30.282023-04-01 → 2023-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥1192022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥29.612022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥30.272023-04-01 → 2023-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥118.952022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥29.62022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio72.0%at 2023-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio69.3%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio70.5%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-06-30¥62m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥1.1bn
jpcrp040300-q1r_E01630-000Blood And Cell Technologies Companyreportable segmentrevenue external2023-04-01 → 2023-06-30¥40.9bn
jpcrp040300-q1r_E01630-000Blood And Cell Technologies Companyreportable segmentsegment profit2023-04-01 → 2023-06-30¥5.9bn
jpcrp040300-q1r_E01630-000Cardiac And Vascular Companyreportable segmentrevenue external2023-04-01 → 2023-06-30¥130.6bn
jpcrp040300-q1r_E01630-000Cardiac And Vascular Companyreportable segmentsegment profit2023-04-01 → 2023-06-30¥26.9bn
jpcrp040300-q1r_E01630-000Medical Care Solutions Companyreportable segmentrevenue external2023-04-01 → 2023-06-30¥43.7bn
jpcrp040300-q1r_E01630-000Medical Care Solutions Companyreportable segmentsegment profit2023-04-01 → 2023-06-30¥2.8bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥215.2bn
—segment totalsegment profit2023-04-01 → 2023-06-30¥35.6bn
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-06-30¥62m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥198m
jpcrp040300-q1r_E01630-000Blood And Cell Technologies Companyreportable segmentrevenue external2022-04-01 → 2022-06-30¥34.5bn
jpcrp040300-q1r_E01630-000Blood And Cell Technologies Companyreportable segmentsegment profit2022-04-01 → 2022-06-30¥3.6bn
jpcrp040300-q1r_E01630-000Cardiac And Vascular Companyreportable segmentrevenue external2022-04-01 → 2022-06-30¥116.8bn
jpcrp040300-q1r_E01630-000Cardiac And Vascular Companyreportable segmentsegment profit2022-04-01 → 2022-06-30¥28.0bn
jpcrp040300-q1r_E01630-000Medical Care Solutions Companyreportable segmentrevenue external2022-04-01 → 2022-06-30¥46.0bn
jpcrp040300-q1r_E01630-000Medical Care Solutions Companyreportable segmentsegment profit2022-04-01 → 2022-06-30¥4.5bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥197.3bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥36.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 561
ItemContextValueUnit
Equity IFRSPrior2YearInstant_CapitalSurplusIFRSMember51921000000JPY
Equity IFRSPrior2YearInstant_TreasurySharesIFRSMember-6229000000JPY
Equity IFRSPrior2YearInstant_RetainedEarningsIFRSMember846978000000JPY
Equity IFRSPrior2YearInstant_OtherComponentsOfEquityIFRSMember80926000000JPY
Equity IFRSPrior2YearInstant_EquityAttributableToOwnersOfParentIFRSMember1012313000000JPY
Equity IFRSPrior2YearInstant1012313000000JPY
Profit loss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember22398000000JPY
Profit loss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember22398000000JPY
Profit loss IFRSPrior1YTDDuration22398000000JPY
Other comprehensive income IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_RetainedEarningsIFRSMember－JPY
Other comprehensive income IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember95345000000JPY
Other comprehensive income IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember95345000000JPY
Other comprehensive income IFRSPrior1YTDDuration95345000000JPY
Comprehensive income IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Comprehensive income IFRSPrior1YTDDuration_RetainedEarningsIFRSMember22398000000JPY
Comprehensive income IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember95345000000JPY
Comprehensive income IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember117743000000JPY
Comprehensive income IFRSPrior1YTDDuration117743000000JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember-0JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember-0JPY
Purchase of treasury shares ss IFRSPrior1YTDDuration-0JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember20000000JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember83000000JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember－JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember-103000000JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember0JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration0JPY
Dividends ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Dividends ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Dividends ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Dividends ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-13613000000JPY
Dividends ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Dividends ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember-13613000000JPY
Dividends ss IFRSPrior1YTDDuration-13613000000JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass